Under construction – not a live service
Sign in
Enrolling by invitationPhase 2

Long-term study of IMG-007 for moderate-to-severe atopic dermatitis

Tests long-term use of IMG-007 in adults with moderate-to-severe atopic dermatitis.

Plain-language title generated from the registry record
Registry title: Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis

Key facts

Where
Anderson, Burien, Charlotte, Columbus, Fargo, Kew Gardens, Lancaster, Los Angeles, Mayfield Heights, New York, Ocala, Portland, Rolling Meadows, Southlake, Tampa, and Woodbury, United StatesSee the 16 sites
Phase
Phase 2

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT07734415, who can take part

Where in United States

  • AndersonAnderson, United StatesNo longer taking part
  • BurienBurien, United StatesNo longer taking part
  • CharlotteCharlotte, United StatesNo longer taking part
  • ColumbusColumbus, United StatesNo longer taking part
  • FargoFargo, United StatesNo longer taking part
  • Kew GardensKew Gardens, United StatesNo longer taking part
  • LancasterLancaster, United StatesNo longer taking part
  • Los AngelesLos Angeles, United StatesNo longer taking part
  • Mayfield HeightsMayfield Heights, United StatesNo longer taking part
  • New YorkNew York, United StatesNo longer taking part
  • OcalaOcala, United StatesNo longer taking part
  • PortlandPortland, United StatesNo longer taking part
  • Rolling MeadowsRolling Meadows, United StatesNo longer taking part
  • SouthlakeSouthlake, United StatesNo longer taking part
  • TampaTampa, United StatesNo longer taking part
  • WoodburyWoodbury, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Inmagene LLC
Trial code
NCT07734415
Record updated
29 July 2026
Original description
The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic dermatitis (AD)Read full original descriptionShow less

A Long-term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous IMG-007 in Participants of a Previous IMG-007 Moderate-To-Severe Atopic Dermatitis Clinical Trial

The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic dermatitis (AD)

Enrolling by invitation participants with moderate to severe AD who have completed IMG-007-203.

ClinicalTrials.gov NCT07734415